BGC - THE COMPLETE STORY !!!!

General Cable (DE) (New stock quotes

General Cable (DE) (New stock charts

Follow this thread / related threads


Cortez - Thu, 01 Jan 04 :



FEBRUARY 2001

ABSTRACT AND COMMENTARY BY:
Attilio Cavezzi, MD
San Benedetto Del Tronto (AP), Italy

Treatment of Varicose Long Saphenous Veins with Sclerosant in Microfoam Form: Long-Term Outcomes
Cabrera J, etc

Sclerotherapy has always been an effective way to treat varicose veins but several studies have shown a high percentage of recanalization on long-term followup. The authors report their experience with sclerosant microfoam treatment of varicose veins as well as their long-term outcomes.

From 1993 to 1996, limbs with varicose veins caused by greater saphenous vein (GSV) incompetence (diameter at the junction of 9 to 32 mm) were treated with a proprietary, patented microfoam of 1 to 3% Lauromacrogol 400. Patients were studied pre- and post-treatment by physical examination and color-flow duplex scanning. They were treated by duplex-guided sclerotherapy with compressive bandages and elastic stockings in the post-treatment period.

The sclerosing foam used in the authors' experience is a microbubble foam of the detergent drug Lauromacrogol 400 coupled with carbon dioxide. This new form of sclerosant permits a greater expansion of the active surface area of the sclerosing drug which is much larger than the active surface of the normal liquid sclerosant. The microfoam was injected through a 20G catheter under duplex guidance and with the patient supine. Generally, 15 to 30 ml of foam was injected into the GSV. Spasm of the treated vessel was the final endpoint.

Results of treatment in 500 GSVs can be summarized as follows: 86% of veins required only one session to achieve immediate sclerosis, 10.5% required a second session, and 3.5% required three sessions. Further injections were necessary during followup to sclerose varicose tributaries. Duplex followup at three or more years revealed fibrosis in 81% of GSVs, a patent GSV without reflux in 5%, and recurrence of reflux in 14%. Disappearance of tributary varicose veins was achieved in 96.5% of limbs. No major complications were reported. Segmental varicophlebitis occurred but it was uncommon.

The authors consider duplex-guided sclerotherapy of the GSV by microfoam to be very effective, even at long-term


General Cable (DE) (New Stock Charts :

General Cable (DE) (New Historic Stock ChartGeneral Cable (DE) (New Intraday Stock Chart
General Cable (DE) (New - Historic Stock ChartGeneral Cable (DE) (New - Historic Stock Chart
Search for a stock: 



By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Affiliate Scheme
Copyright©1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs

ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy

43 site:2us *** bgc081012 22:18 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )